期刊文献+

苯丁酸钠对甲状腺滤泡癌细胞侵袭能力及MMP-9和TIMP-1表达的影响 被引量:6

Effects of sodium phenylbutyrate on invasive ability of human thyroid follicular carcinoma cell line and expression of MMP-9 and TIMP-1
下载PDF
导出
摘要 目的:探讨苯丁酸钠(sodium phenylbutyrate,NaBP)对甲状腺滤泡癌细胞CGTHW-1的侵袭能力及基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)和金属蛋白酶组织抑制剂-1(tissue inhibitor of metalloproteinase,TIMP-1)表达的影响。方法:培养CGTHW-1细胞,通过Transwell侵袭实验观察苯丁酸钠对CGTHW-1细胞侵袭能力的影响,采用免疫细胞化学SP法及RT-PCR观察苯丁酸钠对CGTHW-1细胞中MMP-9和TIMP-1蛋白及mRNA表达的影响。结果:4 mmol/L苯丁酸钠作72 h,CGTHW-1细胞的侵袭细胞数显著减少[(29.8±1.77)vs(11.00±2.59),(P<0.01)]。免疫细胞化学和RT-PCR检测结果显示,4、6 mmol/L苯丁酸钠显著抑制CGTHW-1细胞中MMP-9、TIMP-1蛋白及mRNA的表达(P<0.05)。结论:苯丁酸钠可通过下调MMP-9和TIMP-1的表达进而降低甲状腺滤泡癌CGTHW-1细胞的侵袭能力。 Objective: To investigate the effects of sodium phenylbutyrate ( NaPB ) on the matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 ( TIMP-1 ) expression and invasive ability of human thyroid follicular carcinoma cell line CGTHW-1. Methods: CGTHW-1 cells were treated with different concentrations of NaPB, then the invasive ability of CGTHW-1 cells was assessed using Transwell assay. The expression of MMP-9 and TIMP-1 was exam- ined by immunocytochemistry staining and RT-PCR in CGTHW-1 cells. Results: After treatment with NaPB (4 mmol/L) for 72 h, CGTHW-1 cells passing the Transwell were significantly reduced [ ( 29.8±1.77 ) vs ( 11.00 ± 2.59 ), P 〈 0. 05 ]. Immunocytochemistry staining and RT-PCR demonstrated that protein and mRNA expression of MMP-9 and TIMP- 1 were significantly down-regulated in CGTHW-1 cells after NaPB treatment (4, 6 mmol/L ) (all P 〈 0. 05 ). Conclusion: NaPB can inhibit CGTHW-1 cell invasion by down-regulating MMP-9 and TIMP-1 expression.
作者 孙珂 刘纯
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2009年第1期67-70,共4页 Chinese Journal of Cancer Biotherapy
关键词 苯丁酸钠 甲状腺滤泡癌 侵袭 基质金属蛋白酶-9 金属蛋白酶组织抑制剂-1 sodium phenylbutyratc thyroid fallicular carcinoma invasion metrix metalloproteinase-9 (MMP-9) tissue inhibitor of metalloproteinase-1 ( TIMP-1 )
  • 相关文献

参考文献3

二级参考文献14

  • 1Jonbs JL, Walker RA. Control of matrix metalloproteinase ac tivitv in cancer[J]. J Pathol, 1997,183(4): 377-379.
  • 2Maeta H, Ohgi S,TeradaT. Protein expression of matrix metallo-proteinases 2 and 9 and tissue inhibitors of metalloproteinase 1and 2 in papillary thyroid carcinomas[J]. Virchows Arch,2001,438(2): 121-128.
  • 3Hofmann A, Laue S, Rost AK, et al. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2,and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines[J]. Thyroid, 1998,8(3) :203-214.
  • 4Maruyama S, Kawata R, Shimada T, et al. Study of matrix metallo-proteinase-2 and -9 in thyroid papillary cancer[J]. Nippon Jibiinkoka Gakkai Kaiho, 2000,103 (5): 499-505.
  • 5CHANG TH, SZABO E. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung[J]. Clin Cancer Res, 2002,8 (4): 1206-1212.
  • 6GORE SD, WENG LJ, HGG WD, et al. Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia [J]. Clin Cancer Res, 2002, 8(4) :963-970.
  • 7BOIVIN AJ, MOMPARLER LF, HURTUBISE A, et al. Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells [J]. Anticancer Drugs, 2002,13 (8) :869-874.
  • 8SIAVOSHIAN S, SEGAIN JP, KORNPROBST M, et al. Butyrate and trichostain a effects on the proliferation/differentiation of human intestinal epithelial cells:induction of cyclin D3 and p21 expression [J]. Gut, 2000,46(4) :507-514.
  • 9ARCHER SY, HODIN RA. Histone acetylation and cancer [J].Curr Opin Genet Dev, 1999,9(2) :171-174.
  • 10姚忠强,李力,覃思繁,姚德生,陈发龙,罗元.CD_(44)v3基因蛋白在恶性卵巢肿瘤中的表达及其临床意义[J].中国肿瘤临床,1999,26(8):583-585. 被引量:2

共引文献10

同被引文献79

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部